"Philips Ceases U.S. Sales of CPAP Machines Amid Safety Concerns and Recalls"

Philips, the maker of millions of recalled sleep apnea machines, has agreed to halt sales in the U.S. under a tentative agreement with regulators, potentially costing the company nearly $400 million. The recall was due to risks associated with the breakdown of internal foam in the devices, leading users to inhale particles while sleeping. The company has set aside $393 million to address expenses related to the recall and has promised to prioritize safety and quality. The agreement, which is subject to court approval, requires Philips to continue servicing recalled machines in the U.S. but prohibits the sale of new ones until corrective actions are taken. The recall has led to frustration among patients, with reports of delays in obtaining refunds or replacement devices.